Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
81.79
-1.95 (-2.33%)
At close: Feb 12, 2025, 4:00 PM
81.95
+0.16 (0.20%)
After-hours: Feb 12, 2025, 6:56 PM EST
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $361.12 billion as of February 12, 2025. Its market cap has decreased by -26.72% in one year.
Market Cap
361.12B
Enterprise Value
371.75B
1-Year Change
-26.72%
Ranking
Category
Stock Price
$81.79
Market Cap Chart
Since December 1, 1998, Novo Nordisk's market cap has increased from $5.15B to $361.12B, an increase of 6,905.46%. That is a compound annual growth rate of 17.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 11, 2025 | 373.90B | -3.62% |
Dec 31, 2024 | 387.95B | -17.76% |
Dec 29, 2023 | 471.73B | 54.12% |
Dec 30, 2022 | 306.08B | 19.24% |
Dec 31, 2021 | 256.69B | 55.86% |
Dec 31, 2020 | 164.70B | 16.14% |
Dec 31, 2019 | 141.81B | 23.12% |
Dec 31, 2018 | 115.18B | -15.84% |
Dec 29, 2017 | 136.86B | 46.79% |
Dec 30, 2016 | 93.24B | -38.18% |
Dec 31, 2015 | 150.82B | 29.59% |
Dec 31, 2014 | 116.38B | 12.48% |
Dec 31, 2013 | 103.47B | 9.30% |
Dec 31, 2012 | 94.66B | 36.88% |
Dec 30, 2011 | 69.16B | -0.91% |
Dec 31, 2010 | 69.79B | 72.41% |
Dec 31, 2009 | 40.48B | 26.82% |
Dec 31, 2008 | 31.92B | -22.43% |
Dec 31, 2007 | 41.15B | 52.03% |
Dec 29, 2006 | 27.07B | 44.82% |
Dec 30, 2005 | 18.69B | 1.87% |
Dec 31, 2004 | 18.35B | 29.73% |
Dec 31, 2003 | 14.14B | 41.73% |
Dec 31, 2002 | 9.98B | 25.01% |
Dec 29, 2000 | 7.98B | 36.89% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 786.97B |
UnitedHealth Group | 486.96B |
Johnson & Johnson | 373.70B |
AbbVie | 340.03B |
Abbott Laboratories | 225.84B |
AstraZeneca | 223.90B |
Merck & Co. | 216.71B |
Novartis AG | 211.30B |